Clearmind Medicine Inc.
CMND · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $213,680 | $203,414 | $247,738 | $226,848 |
| - Cash | $3,495 | $4,473 | $5,781 | $6,574 |
| + Debt | $28 | $36 | $46 | $53 |
| Enterprise Value | $210,213 | $198,977 | $242,002 | $220,327 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$13 | -$12 | -$12 | -$12 |
| % Margin | – | – | – | – |
| EBITDA | -$1,284 | -$1,295 | -$1,012 | -$1,180 |
| % Margin | – | – | – | – |
| Net Income | -$1,314 | -$784 | -$1,072 | -$885 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.21 | -0.35 | -0.3 |
| % Growth | -61.9% | 40% | -16.7% | – |
| Operating Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |